Neuroleptic malignant syndrome and catatonia: one entity or two?
Fink
M
M
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002389:Catatonia / Q000139:chemically induced* / Q000175:diagnosis; D003937:Diagnosis, Differential; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis*; D009460:Neurologic Examination / Q000187:drug effects; D013577:Syndrome
D014150:Antipsychotic Agents